Zscaler (ZS) 10-Q 7 Dec 22 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Oct. 31, 2022	Nov. 30, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-38413
Entity Registrant Name	ZSCALER, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1173892
Entity Address, Address Line One	120 Holger Way
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	533-0288
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	ZS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares Outstanding		144,212,227
Entity Central Index Key	0001713683
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,084,945	$ 1,013,210
Short-term investments	739,845	718,129
Accounts receivable, net	268,718	399,745
Deferred contract acquisition costs	90,004	86,210
Prepaid expenses and other current assets	49,849	39,353
Total current assets	2,233,361	2,256,647
Property and equipment, net	183,425	160,633
Operating lease right-of-use assets	76,199	72,357
Deferred contract acquisition costs, noncurrent	211,468	210,792
Acquired intangible assets, net	29,267	31,819
Goodwill	78,547	78,547
Other noncurrent assets	23,465	21,870
Total assets	2,835,732	2,832,665
Current liabilities:
Accounts payable	29,717	26,154
Accrued expenses and other current liabilities	60,229	46,496
Accrued compensation	79,587	111,948
Deferred revenue	913,104	923,749
Operating lease liabilities	28,646	26,100
Total current liabilities	1,111,283	1,134,447
Convertible senior notes, net	1,139,542	968,674
Deferred revenue, noncurrent	92,609	97,374
Operating lease liabilities, noncurrent	51,065	50,948
Other noncurrent liabilities	9,958	7,922
Total liabilities	2,404,457	2,259,365
Commitments and contingencies (Note 9)
Stockholders’ Equity
Common stock; $0.001 par value; 1,000,000 shares authorized as of October 31, 2022 and July 31, 2022; 144,210 and 143,038 shares issued and outstanding as of October 31, 2022 and July 31, 2022, respectively	144	143
Additional paid-in capital	1,425,156	1,590,885
Accumulated other comprehensive loss	(37,824)	(25,850)
Accumulated deficit	(956,201)	(991,878)
Total stockholders’ equity	431,275	573,300
Total liabilities and stockholders’ equity	$ 2,835,732	$ 2,832,665

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2022	Jul. 31, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	144,210,000	143,038,000
Common stock, shares outstanding (in shares)	144,210,000	143,038,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Income Statement [Abstract]
Revenue	$ 355,548	$ 230,517
Cost of revenue	76,697	52,169
Gross profit	278,851	178,348
Operating expenses:
Sales and marketing	228,836	153,786
Research and development	74,946	65,216
General and administrative	44,156	33,717
Total operating expenses	347,938	252,719
Loss from operations	(69,087)	(74,371)
Interest income	7,865	473
Interest expense	(1,331)	(13,835)
Other expense, net	(863)	(589)
Loss before income taxes	(63,416)	(88,322)
Provision for income taxes	4,746	2,479
Net loss	$ (68,162)	$ (90,801)
Net loss per share, basic (in dollars per share)	$ (0.48)	$ (0.65)
Net loss per share, diluted (in dollars per share)	$ (0.48)	$ (0.65)
Weighted-average shares used in computing net loss per share, basic (in shares)	143,476	139,296
Weighted-average shares used in computing net loss per share, diluted (in shares)	143,476	139,296

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (68,162)	$ (90,801)
Available-for-sale securities:
Change in net unrealized losses on available-for-sale securities	(2,648)	(1,164)
Cash flow hedging instruments:
Change in net unrealized losses	(14,039)	(1,304)
Net realized losses reclassified into net loss	4,713	354
Net change on cash flow hedges	(9,326)	(950)
Other comprehensive loss	(11,974)	(2,114)
Comprehensive loss	$ (80,136)	$ (92,915)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	$ 1,131,006		$ (650)	$ (601,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			387
Issuance of common stock upon exercise of stock options	2,644			2,644
Vesting of restricted stock units and other stock issuances (in shares)			983
Vesting of restricted stock units and other stock issuances	0		$ 1	(1)
Stock-based compensation	91,575			91,575
Other comprehensive loss	(2,114)					(2,114)
Net loss	(90,801)						(90,801)
Ending balance (in shares) at Oct. 31, 2021			140,032
Ending balance at Oct. 31, 2021	530,199		$ 140	1,225,224		(2,764)	(692,401)
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	1,131,006		(650)	(601,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Ending balance (in shares) at Jul. 31, 2022	143,038		143,038
Ending balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	1,590,885	$ (273,738)	(25,850)	(991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	109		109
Issuance of common stock upon exercise of stock options	$ 982			982
Vesting of restricted stock units and other stock issuances (in shares)			1,063
Vesting of restricted stock units and other stock issuances	0		$ 1	(1)
Stock-based compensation	107,028			107,028
Other comprehensive loss	(11,974)					(11,974)
Net loss	$ (68,162)						(68,162)
Ending balance (in shares) at Oct. 31, 2022	144,210		144,210
Ending balance at Oct. 31, 2022	$ 431,275		$ 144	$ 1,425,156		$ (37,824)	$ (956,201)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		3 Months Ended
		Oct. 31, 2022	Oct. 31, 2021
Cash Flows From Operating Activities
Net loss		$ (68,162)	$ (90,801)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization expense		11,876	9,017
Amortization expense of acquired intangible assets		2,552	2,226
Amortization of deferred contract acquisition costs		22,325	14,912
Amortization of debt discount and issuance costs		972	13,476
Non-cash operating lease costs		7,108	6,031
Stock-based compensation expense		105,173	89,903
Amortization (accretion) of investments purchased at a premium (discount)		(165)	2,671
Deferred income taxes		65	(223)
Other		248	(13)
Changes in operating assets and liabilities
Accounts receivable		130,636	84,927
Deferred contract acquisition costs		(26,795)	(23,985)
Prepaid expenses, other current and noncurrent assets		(7,579)	(4,126)
Accounts payable		3,000	(1,088)
Accrued expenses, other current and noncurrent liabilities		3,627	(192)
Accrued compensation		(32,797)	(20,955)
Deferred revenue		(15,340)	17,381
Operating lease liabilities		(8,287)	(5,890)
Net cash provided by operating activities		128,457	93,271
Cash Flows From Investing Activities
Purchases of property, equipment and other assets		(25,202)	(6,454)
Capitalized internal-use software		(7,641)	(3,450)
Strategic investments		(700)	0
Purchases of short-term investments		(210,255)	(312,840)
Proceeds from maturities of short-term investments		186,096	322,677
Net cash used in investing activities		(57,702)	(67)
Cash Flows From Financing Activities
Proceeds from issuance of common stock upon exercise of stock options		982	2,644
Payment of deferred consideration related to business acquisitions		0	(50)
Other		(2)	0
Net cash provided by financing activities		980	2,594
Net increase in cash and cash equivalents	[1]	71,735	95,798
Cash and cash equivalents at beginning of period	[1]	1,013,210	275,898
Cash and cash equivalents at end of period	[1]	1,084,945	371,696
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes, net of tax refunds		3,003	2,479
Non-Cash Activities
Operating lease right-of-use assets obtained in exchange for operating lease obligations, net of terminations		10,390	5,426
Net change in purchased equipment included in accounts payable and accrued expenses		$ 1,592	$ 2,906
[1]We did not hold restricted cash for any periods presented.

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	3 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies Description of the Business Zscaler, Inc. ("Zscaler," the "Company," "we," "us," or "our") is a cloud security company that developed a platform incorporating core security functionalities needed to enable fast and secure access to cloud resources based on identity, context and organization’s policies. Our solution is a purpose-built, multi-tenant, distributed cloud platform that incorporates the security functionality needed to enable users, applications, and devices to safely and efficiently utilize authorized applications and services based on an organization’s business policies. We deliver our solutions using a software-as-a-service ("SaaS") business model and sell subscriptions to customers to access our cloud platform, together with related support services. We were incorporated in Delaware in September 2007 and conduct business worldwide, with presence in North America, Europe and Asia. Our headquarters are in San Jose, California. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2022 (the "Fiscal 2022 Form 10-K"), as filed with the SEC on September 15, 2022. Interim Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of July 31, 2022 was derived from the audited consolidated financial statements as of that date. The accompanying interim condensed consolidated financial statements, including the condensed consolidated balance sheet as of October 31, 2022, the condensed consolidated statements of operations for the three months ended October 31, 2022 and 2021, the condensed consolidated statements of comprehensive loss for the three months ended October 31, 2022 and 2021, the condensed consolidated statements of stockholders’ equity for the three months ended October 31, 2022 and 2021 and the condensed consolidated statements of cash flows for the three months ended October 31, 2022 and 2021 are unaudited. The related financial data and the other financial information disclosed in the accompanying notes to these condensed consolidated financial statements are also unaudited. These interim unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual consolidated financial statements and, in our opinion, include all normal recurring adjustments necessary to state fairly our quarterly results. The results of operations for the three months ended October 31, 2022 are not necessarily indicative of the results to be expected for our fiscal year ending July 31, 2023 or for any other future fiscal year or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal use software development costs, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value and effective interest rate of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including effects of COVID-19 and inflation, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained . Fiscal Year Our fiscal year ends on July 31. References to fiscal 2023, for example, refer to our fiscal year ending July 31, 2023. Significant Accounting Policies Our significant accounting policies are described in the Fiscal 2022 Form 10-K. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and related notes for the three months ended October 31, 2022 other than for the adoption of new accounting guidance related to convertible debt effective August 1, 2022 further described below. Recently Adopted Accounting Pronouncements In June 2020, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06"). This standard removes the separation model for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. We adopted this standard effective on August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. In accordance with the adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. This standard resulted in our convertible senior notes being accounted for as a single unit of debt and we will no longer be required to record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. Prior to the adoption of this standard, we used the treasury stock method to calculate the potentially diluted effect of the convertible senior notes; however, upon adoption of this standard we are required to use the if-converted method. Accordingly, to

Revenue Recognition

Revenue Recognition	3 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Subscription and support revenue is recognized over time and accounted for approximately 97% of our revenue for each of the three months ended October 31, 2022 and 2021. The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended October 31, 2022 2021 Amount % Revenue Amount % Revenue (in thousands, except per percentage data) United States $ 175,515 49 % $ 113,413 49 % Europe, Middle East and Africa 116,993 33 % 80,549 35 % Asia Pacific 52,270 15 % 31,052 14 % Other 10,770 3 % 5,503 2 % Total $ 355,548 100 % $ 230,517 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended October 31, 2022 2021 Amount % Revenue Amount % Revenue (in thousands, except per percentage data) Channel partners $ 329,357 93 % $ 215,073 93 % Direct customers 26,191 7 % 15,444 7 % Total $ 355,548 100 % $ 230,517 100 % Significant Customers No single customer accounted for 10% or more of the total revenue or the total balance of accounts receivable, net in the periods presented. Contract Balances Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. Deferred revenue, including current and noncurrent balances as of October 31, 2022 and July 31, 2022 was $1,005.7 million and $1,021.1 million, respectively. In the three months ended October 31, 2022 and 2021, we recognized revenue of $329.3 million and $206.4 million, respectively, that was included in the corresponding contract liability balance at the beginning of these periods. Remaining Performance Obligations The typical subscription and support term is one Costs to Obtain and Fulfill a Contract We capitalize sales commission and associated payroll taxes paid to internal sales personnel that are incremental to the acquisition of channel partner and direct customer contracts. These costs are recorded as deferred contract acquisition costs in the condensed consolidated balance sheets. The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended October 31, 2022 2021 (in thousands) Beginning balance $ 297,002 $ 207,030 Capitalization of contract acquisition costs 26,795 23,985 Amortization of deferred contract acquisition costs (22,325) (14,912) Ending balance $ 301,472 $ 216,103 The outstanding balance of the deferred contract acquisition costs consisted of the following: October 31, 2022 July 31, 2022 (in thousands) Deferred contract acquisition costs, current $ 90,004 $ 86,210 Deferred contract acquisition costs, noncurrent 211,468 210,792 Total deferred contract acquisition costs $ 301,472 $ 297,002 Sales commissions accrued but not paid as of October 31, 2022 and July 31, 2022, totaled $21.0 million and $47.2 million, respectively, which are included within accrued compensation in the condensed consolidated balance sheets.

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	3 Months Ended
	Oct. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments Cash equivalents and short-term investments consisted of the following as of October 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 157,756 $ — $ — $ 157,756 U.S. treasury securities 133,029 — (19) 133,010 U.S. government agency securities 336,570 — (126) 336,444 Corporate debt securities 225,568 — (1) 225,567 Total cash equivalents $ 852,923 $ — $ (146) $ 852,777 Short-term investments: U.S. treasury securities $ 174,577 $ 5 $ (218) $ 174,364 U.S. government agency securities 320,065 — (8,425) 311,640 Corporate debt securities 259,696 — (5,855) 253,841 Total short-term investments $ 754,338 $ 5 $ (14,498) $ 739,845 Total cash equivalents and short-term investments $ 1,607,261 $ 5 $ (14,644) $ 1,592,622 Cash equivalents and short-term investments consisted of the following as of July 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 247,613 $ — $ — $ 247,613 U.S. treasury securities 202,778 — (70) 202,708 U.S. government agency securities 135,525 2 (38) 135,489 Corporate debt securities 106,272 — — 106,272 Total cash equivalents $ 692,188 $ 2 $ (108) $ 692,082 Short-term investments: U.S. treasury securities $ 96,089 $ 10 $ (251) $ 95,848 U.S. government agency securities 339,957 6 (6,628) 333,335 Corporate debt securities 293,968 — (5,022) 288,946 Total short-term investments $ 730,014 $ 16 $ (11,901) $ 718,129 Total cash equivalents and short-term investments $ 1,422,202 $ 18 $ (12,009) $ 1,410,211 The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of October 31, 2022: Amortized Fair Value (in thousands) Due within one year $ 560,556 $ 555,971 Due between one to three years 193,782 183,874 Total $ 754,338 $ 739,845 Short-term investments that were in an unrealized loss position as of October 31, 2022, consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 149,458 $ (116) $ 9,898 $ (102) $ 159,356 $ (218) U.S. government agency securities 120,505 (1,966) 191,135 (6,459) 311,640 (8,425) Corporate debt securities 60,270 (2,518) 146,058 (3,337) 206,328 (5,855) Total $ 330,233 $ (4,600) $ 347,091 $ (9,898) $ 677,324 $ (14,498) Short-term investments that were in an unrealized loss position consisted of the following as of July 31, 2022, consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 80,833 $ (251) $ — $ — $ 80,833 $ (251) U.S. government agency securities 230,670 (5,150) 50,134 (1,478) 280,804 (6,628) Corporate debt securities 155,968 (3,947) 71,127 (1,075) 227,095 (5,022) Total $ 467,471 $ (9,348) $ 121,261 $ (2,553) $ 588,732 $ (11,901) We review the individual securities that have unrealized losses in our short-term investment portfolio on a regular basis. We evaluate, among others, whether we have the intention to sell any of these investments and whether it is not more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met in any period presented. We additionally evaluate whether the decline in fair value of the corporate debt securities below its amortized cost basis is related to credit losses or other factors. Based on this evaluation, we determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and non-credit related factors. Accordingly, we determined that an allowance for credit losses was unnecessary for our short-term investments as of October 31, 2022 and July 31, 2022. We recorded $1.5 million and $1.3 million of accrued interest receivable within prepaid expenses and other current assets in the condensed consolidated balance sheets as of October 31, 2022 and July 31, 2022, respectively.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our money market funds are classified within Level I due to the highly liquid nature of these assets and have quoted prices in active markets. Certain of our investments in available-for-sale securities (i.e., U.S. treasury securities, U.S. government agency securities and corporate debt securities), as well as our assets and liabilities arising from our foreign currency forward contracts, are classified within Level II. The fair value of our Level II financial assets and liabilities is determined by using inputs based on non-binding market consensus prices that are primarily corroborated by observable market data or quoted market prices for similar instruments, for substantially the full term of the financial assets and liabilities. Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of October 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 157,756 $ 157,756 $ — $ — U.S. treasury securities 133,010 — 133,010 — U.S. government agency securities 336,444 — 336,444 — Corporate debt securities 225,567 — 225,567 — Total cash equivalents $ 852,777 $ 157,756 $ 695,021 $ — Short-term investments: U.S. treasury securities $ 174,364 $ — $ 174,364 $ — U.S. government agency securities 311,640 — 311,640 — Corporate debt securities 253,841 — 253,841 — Total short-term investments $ 739,845 $ — $ 739,845 $ — Total cash equivalents and short-term investments $ 1,592,622 $ 157,756 $ 1,434,866 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 574 $ — $ 574 $ — Foreign currency contract assets-noncurrent (2) $ 1,402 $ — $ 1,402 $ — Foreign currency contracts liabilities-current (3) $ 20,207 $ — $ 20,207 $ — Foreign currency contracts liabilities-noncurrent (4) $ 1,718 $ — $ 1,718 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 615 $ — $ 615 $ — Foreign currency contracts liabilities-current (3) $ 4,232 $ — $ 4,232 $ — (1) Reported as prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Reported as other noncurrent assets in the condensed consolidated balance sheets. (3) Reported as accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Reported as other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Reported as prepaid expenses and other current assets in the consolidated balance sheets. (2) Reported as other noncurrent assets in the consolidated balance sheets. (3) Reported as accrued expenses and other current liabilities in the consolidated balance sheets. (4) Reported as other noncurrent liabilities in the consolidated balance sheets. We did not have transfers between levels of the fair value hierarchy of assets measured at fair value during the periods presented. Refer to Note 8, Convertible Senior Notes, for the carrying amount and estimated fair value of our convertible senior notes as of October 31, 2022 and July 31, 2022.

Property and Equipment and Purc

Property and Equipment and Purchased Intangible Assets	3 Months Ended
	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: October 31, 2022 July 31, 2022 (in thousands) Hosting equipment $ 214,698 $ 191,037 Capitalized internal-use software 83,915 72,267 Computers and equipment 7,147 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,024 1,022 Leasehold improvements 7,339 7,339 Total property and equipment, gross 315,434 279,750 Less: Accumulated depreciation and amortization (132,009) (119,117) Total property and equipment, net $ 183,425 $ 160,633 Purchased intangible assets consist of internet protocol (IP) addresses, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of October 31, 2022, their historical cost and accumulated amortization was $8.6 million and $1.0 million, respectively. As of July 31, 2022, their historical cost and accumulated amortization was $6.4 million and $0.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $11.9 million and $9.0 million for the three months ended October 31, 2022 and 2021, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with the capitalization of development costs of software for internal-use of $1.7 million and $0.8 million for the three months ended October 31, 2022 and 2021, respectively.
Property and Equipment and Purchased Intangible Assets	Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: October 31, 2022 July 31, 2022 (in thousands) Hosting equipment $ 214,698 $ 191,037 Capitalized internal-use software 83,915 72,267 Computers and equipment 7,147 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,024 1,022 Leasehold improvements 7,339 7,339 Total property and equipment, gross 315,434 279,750 Less: Accumulated depreciation and amortization (132,009) (119,117) Total property and equipment, net $ 183,425 $ 160,633 Purchased intangible assets consist of internet protocol (IP) addresses, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of October 31, 2022, their historical cost and accumulated amortization was $8.6 million and $1.0 million, respectively. As of July 31, 2022, their historical cost and accumulated amortization was $6.4 million and $0.8 million, respectively. Purchased intangible assets are included within other noncurrent assets in the condensed consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $11.9 million and $9.0 million for the three months ended October 31, 2022 and 2021, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with the capitalization of development costs of software for internal-use of $1.7 million and $0.8 million for the three months ended October 31, 2022 and 2021, respectively.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	3 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill The carrying amount of goodwill was $78.5 million as of October 31, 2022 and July 31, 2022. Acquired Intangible Assets Acquired intangible assets consist of developed technology and customer relationships acquired through our business combinations and asset acquisitions. Acquired intangible assets are amortized using the straight-line method over their estimated useful lives. Acquired intangible assets subject to amortization consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount July 31, 2022 Additions October 31, 2022 July 31, 2022 Amortization Expense October 31, 2022 July 31, 2022 October 31, 2022 (in thousands) Developed technology $ 48,356 $ — $ 48,356 $ (18,972) $ (2,374) $ (21,346) $ 29,384 $ 27,010 Customer relationships 3,560 — 3,560 (1,125) (178) (1,303) 2,435 2,257 Total $ 51,916 $ — $ 51,916 $ (20,097) $ (2,552) $ (22,649) $ 31,819 $ 29,267 Amortization expense of acquired intangible assets for the three months ended October 31, 2022 and 2021 was $2.6 million and $2.2 million, respectively. Amortization expense of developed technology and customer relationships is recorded primarily within cost of revenue and sales and marketing expenses, respectively, in the condensed consolidated statements of operations. Future amortization expense of acquired intangible assets consisted of the following: October 31, 2022 Year ending July 31, (in thousands) 2023 (remaining nine months) $ 7,369 2024 8,481 2025 7,778 2026 4,232 2027 1,407 Total $ 29,267

Derivative Instruments

Derivative Instruments	3 Months Ended
	Oct. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments As a global business, we are exposed to foreign currency exchange rate risk. Substantially all of our revenue is transacted in U.S. dollars; however, a portion of our cost of revenue and operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. In order to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts, which we designate as cash flow hedges. All cash flow hedges were considered effective during the three months ended October 31, 2022 and 2021. We also use foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. The outstanding non-designated derivative instruments are carried at fair value with change in fair value recorded in other expense, net in the condensed consolidated statement of operations in the same period as the changes in fair value from the remeasurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. These foreign exchange contracts typically have maturities of approximately one As of October 31, 2022 and July 31, 2022, the total notional amount of our outstanding designated foreign currency forward contracts was $446.1 million and $293.4 million, respectively, and for our outstanding non-designated foreign currency forward contracts and $162.4 million and $126.4 million, respectively. The maximum length of time over which forecasted foreign currency denominated operating expenses are hedged is 24 months. Substantially all of the unrealized gains and losses related to our cash flow hedges are expected to be released into earnings over the next 12 months. Refer to Note 4, Fair Value Measurements, for the fair value of our derivative instruments as reported on the condensed consolidated balance sheet as of October 31, 2022 and July 31, 2022. During the three months ended October 31, 2022 and 2021, changes in the fair value of our non-designated derivative instruments recorded in other expense, net within the condensed consolidated statements of operations were not material. During the three months ended October 31, 2022 and 2021, the loss recognized in accumulated other comprehensive income (loss) ("AOCI") related to our cash flow hedges was $14.0 million and $1.3 million, respectively. The following table presents information about (gains) losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations for three months ended October 31, 2022 and 2021 : Three Months Ended October 31, 2022 2021 (in thousands) Classification: Cost of revenue $ 708 $ 5 Sales and marketing 3,297 380 Research and development 464 (27) General and administrative 244 (4) Total $ 4,713 $ 354 Our derivative contracts expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the underlying contracts. We mitigate this credit risk by transacting with major financial institutions with high credit ratings and standards. We periodically assess the creditworthiness of our counterparties to ensure they continue to meet our credit quality requirements. We also enter into master netting arrangements, which permit net settlement of transactions with the same counterparty. The potential impact of these rights of set-off associated with our derivative instruments was not material as of October 31, 2022 and July 31, 2022. We are not required to pledge, and are not entitled to receive, cash collateral related to these derivative instruments. We do not enter into derivative contracts for trading or speculative purposes.

Convertible Senior Notes

Convertible Senior Notes	3 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 25, 2020, we issued $1,150.0 million in aggregate principal amount of 0.125% Convertible Senior Notes due 2025 (the “Notes”), including the exercise in full by the initial purchasers of the Notes of their option to purchase an additional $150.0 million principal amount of the Notes. The Notes are unsecured obligations and bear interest at a rate of 0.125% per year and interest is payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes mature on July 1, 2025, unless earlier converted, redeemed or repurchased. The total net proceeds from the offering, after deducting initial purchase discounts and other debt issuance costs, was $1,130.5 million. Refer to Note 9, Convertible Senior Notes, in the Notes to Consolidated Financial Statements included in our Fiscal 2022 Form 10-K for further information on the Notes. During the three months ended October 31, 2022, the conditions allowing holders of the Notes to convert were not met. The net carrying amount of the liability component of the Notes consisted of the following: October 31, July 31, 2022 2022 (in thousands) Principal amount $ 1,149,993 $ 1,149,995 Less: Unamortized debt discount (1) — 172,169 Unamortized debt issuance costs (1) 10,451 9,152 Net carrying amount $ 1,139,542 $ 968,674 (1) Effective August 1, 2022, we adopted ASU 2020-06. The adoption of this standard resulted in the elimination of the amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity will be classified to debt and amortized as interest expense. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended October 31, 2022 2021 (in thousands) Contractual interest expense $ 359 $ 359 Amortization of debt discount (1) — 12,796 Amortization of debt issuance costs (1) 972 680 Total $ 1,331 $ 13,835 (1) The decrease in total interest expense for the period ended October 31, 2022, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies. The total fair value of the Notes was $1,416.7 million and $1,418.5 million as of October 31, 2022 and July 31, 2022, respectively. The fair value was determined based on the closing trading price per $1,000 of the Notes as of the last day of trading for the period. We consider the fair value of the Notes as of October 31, 2022 to be a Level II measurement as they are not actively traded. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various third parties to purchase products and services such as technology equipment, subscription-based cloud service arrangements, corporate and marketing events and consulting services. During the three months ended October 31, 2022, there have been no material changes outside the ordinary course of business to our non-cancelable purchase commitments from those disclosed in our Fiscal 2022 Form 10-K. Other Commitments As of October 31, 2022 and July 31, 2022, we had outstanding irrevocable standby unsecured letters of credits for an aggregate value of $2.1 million with a bank, which serve as security under certain real estate leases. Legal Matters Litigation and Claims We are a party to various litigation matters from time to time and subject to claims that arise in the ordinary course of business, including patent, commercial, product liability, employment, class action, whistleblower and other litigation and claims, as well as governmental and other regulatory investigations and proceedings. In addition, third parties may from time to time assert claims against us in the form of letters and other communications. There is no pending or threatened legal proceeding to which we are a party that, in our opinion, is likely to have a material adverse effect on our future financial results or operations; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. The expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change and could adversely affect our results of operations.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan Equity incentive awards which may be granted to eligible participants under our Fiscal Year 2018 Equity Incentive Plan (the "Plan") include restricted stock units, restricted stock, stock options, nonstatutory stock options, stock appreciation rights, performance units and performance shares. Stock Options The activity of stock options consisted of the following for three months ended October 31, 2022: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2022 1,673 $ 11.81 2.5 $ 240,286 Exercised (109) 8.63 18,290 Canceled, forfeited or expired — — Balance as of October 31, 2022 1,564 $ 12.04 2.3 $ 222,120 Exercisable and expected to vest as of July 31, 2022 1,501 $ 10.78 2.4 $ 216,539 Exercisable and expected to vest as of October 31, 2022 1,441 $ 11.21 2.2 $ 205,855 The aggregate intrinsic value of the options exercised represents the difference between the fair value of our common stock on the date of exercise and their exercise price. The total intrinsic value of options exercised for the three months ended October 31, 2022 and 2021 was $18.3 million and $100.7 million, respectively. There were no stock options granted during the periods presented. Restricted Stock Units and Performance Stock Awards The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for three months ended October 31, 2022: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2022 7,388 $ 157.17 $ 1,145,526 Granted 1,637 174.79 Vested (1,019) 164.91 179,139 Canceled or forfeited (523) 167.95 Balance as of October 31, 2022 7,483 $ 159.22 $ 1,153,071 As of October 31, 2022, there were 0.1 million outstanding PSAs for which the performance metrics have not been defined as of such date. Accordingly, such awards are not considered granted for accounting purposes as of October 31, 2022 and have been excluded from the above table. Employee Stock Purchase Plan In fiscal 2018, we adopted the Fiscal Year 2018 Employee Stock Purchase Plan (the "ESPP"). ESPP employee payroll contributions accrued as of October 31, 2022 and July 31, 2022, were $12.6 million and $4.7 million, respectively, and are reported within accrued compensation in the condensed consolidated balance sheets. Payroll contributions accrued as of October 31, 2022 will be used to purchase shares at the end of the current ESPP purchase period ending on December 15, 2022. Payroll contributions ultimately used to purchase shares are reclassified to stockholders’ equity on the purchase date. There were no shares issued under the ESPP during the periods presented. Departure of the President of the Company In October 2022, our President resigned from his position as President of the Company, but will continue serving as a member of our Board of Directors. In connection with his resignation as President of the Company, we recognized a reversal of stock-based compensation of $9.9 million associated with the cancellation of unvested incentive equity awards, which was recognized in research and development expenses in the condensed consolidated statement of operations for the three months ended October 31, 2022. Modification of Equity Awards During the three months ended October 31, 2022, we modified the equity awards of certain employees. In accordance with the accounting for the modification, we recognized stock-based compensation expense of $5.6 million in research and development expenses in the condensed consolidated statement of operations for the three months ended October 31, 2022. Stock-based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended October 31, 2022 2021 (in thousands) Cost of revenue $ 8,432 $ 4,986 Sales and marketing 53,635 40,720 Research and development 24,531 27,259 General and administrative 18,575 16,938 Total $ 105,173 $ 89,903

Income Taxes

Income Taxes	3 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, we update our estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, we make a cumulative adjustment in such period. Our quarterly tax provision, and estimate of our annual effective tax rate, is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, changes in how we do business, and tax law developments. Our estimated annual effective tax rate for the year differs from the U.S. statutory rate of 21% as a result of our U.S. losses for which no benefit will be realized, as well as our foreign operations which are subject to tax rates that differ from those in the United States. We recorded provision for income taxes of $4.7 million and $2.5 million for the three months ended October 31, 2022 and 2021, respectively. The increase in the provision for income taxes for the three months ended October 31, 2022 was due to the increase in our pre-tax income in the foreign jurisdictions in which we conduct business, and the effects of a tax law change related to mandatory capitalization of research and development expenses for tax years starting January 1, 2022. We are subject to income tax in the United States as well as other tax jurisdictions in which we conduct business. Earnings from our non-U.S. operations are subject to income taxes in the countries in which we operate.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended 2022 2021 (in thousands) Net loss $ (68,162) $ (90,801) Weighted-average shares used in computing net loss per share, basic and diluted 143,476 139,296 Net loss per share, basic and diluted $ (0.48) $ (0.65) Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented. Prior to the adoption of ASU 2020-06, we calculated the potential dilutive effect of the Notes under the treasury stock method. As a result, only the amount by which the conversion value exceeded the aggregate principal amount of the Notes (the “conversion spread”) was considered in the diluted earnings per share computation. The conversion spread only had a dilutive impact on diluted net income per share when the average market price of our common stock for a given reporting period exceeded the initial conversion price of $150.80 per share for the Notes. Upon the adoption of ASU 2020-06 on August 1, 2022, we calculate the potential dilutive effect of the Notes under the if-converted method. Under this method, diluted earnings per share is determined by assuming that all of the Notes were converted into shares of our common stock at the beginning of the reporting period. In connection with the issuance of the Notes, we entered into Capped Calls, which were not included for purposes of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes. We have not exercised any of the Capped Calls as of October 31, 2022. The following table summarizes the potentially dilutive securities outstanding as of October 31, 2022 and 2021 that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: October 31, 2022 2021 (in thousands) Unvested RSUs and shares of common stock 6,870 7,085 Stock options 1,564 2,206 Unvested PSAs (1) 755 676 Share purchase rights under the ESPP 812 697 Notes 7,626 7,626 Total 17,627 18,290 (1)

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States ("GAAP") and applicable regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and related notes in its Annual Report on Form 10-K for the fiscal year ended July 31, 2022 (the "Fiscal 2022 Form 10-K"), as filed with the SEC on September 15, 2022.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal use software development costs, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value and effective interest rate of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the condensed consolidated financial statements. Due to uncertainty in the macroeconomic environment, including effects of COVID-19 and inflation, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained .
Fiscal Year	Fiscal Year Our fiscal year ends on July 31. References to fiscal 2023, for example, refer to our fiscal year ending July 31, 2023.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2020, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06"). This standard removes the separation model for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. We adopted this standard effective on August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. In accordance with the adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. This standard resulted in our convertible senior notes being accounted for as a single unit of debt and we will no longer be required to record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. Prior to the adoption of this standard, we used the treasury stock method to calculate the potentially diluted effect of the convertible senior notes; however, upon adoption of this standard we are required to use the if-converted method. Accordingly, to

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Three Months Ended October 31, 2022 2021 Amount % Revenue Amount % Revenue (in thousands, except per percentage data) United States $ 175,515 49 % $ 113,413 49 % Europe, Middle East and Africa 116,993 33 % 80,549 35 % Asia Pacific 52,270 15 % 31,052 14 % Other 10,770 3 % 5,503 2 % Total $ 355,548 100 % $ 230,517 100 % The following table summarizes the revenue from contracts by type of customer: Three Months Ended October 31, 2022 2021 Amount % Revenue Amount % Revenue (in thousands, except per percentage data) Channel partners $ 329,357 93 % $ 215,073 93 % Direct customers 26,191 7 % 15,444 7 % Total $ 355,548 100 % $ 230,517 100 %
Capitalized Contract Cost	The activity of the deferred contract acquisition costs consisted of the following: Three Months Ended October 31, 2022 2021 (in thousands) Beginning balance $ 297,002 $ 207,030 Capitalization of contract acquisition costs 26,795 23,985 Amortization of deferred contract acquisition costs (22,325) (14,912) Ending balance $ 301,472 $ 216,103 The outstanding balance of the deferred contract acquisition costs consisted of the following: October 31, 2022 July 31, 2022 (in thousands) Deferred contract acquisition costs, current $ 90,004 $ 86,210 Deferred contract acquisition costs, noncurrent 211,468 210,792 Total deferred contract acquisition costs $ 301,472 $ 297,002

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	3 Months Ended
	Oct. 31, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Cash Equivalents and Short-Term Investments	Cash equivalents and short-term investments consisted of the following as of October 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 157,756 $ — $ — $ 157,756 U.S. treasury securities 133,029 — (19) 133,010 U.S. government agency securities 336,570 — (126) 336,444 Corporate debt securities 225,568 — (1) 225,567 Total cash equivalents $ 852,923 $ — $ (146) $ 852,777 Short-term investments: U.S. treasury securities $ 174,577 $ 5 $ (218) $ 174,364 U.S. government agency securities 320,065 — (8,425) 311,640 Corporate debt securities 259,696 — (5,855) 253,841 Total short-term investments $ 754,338 $ 5 $ (14,498) $ 739,845 Total cash equivalents and short-term investments $ 1,607,261 $ 5 $ (14,644) $ 1,592,622 Cash equivalents and short-term investments consisted of the following as of July 31, 2022: Amortized Unrealized Unrealized Fair Value Cash equivalents: (in thousands) Money market funds $ 247,613 $ — $ — $ 247,613 U.S. treasury securities 202,778 — (70) 202,708 U.S. government agency securities 135,525 2 (38) 135,489 Corporate debt securities 106,272 — — 106,272 Total cash equivalents $ 692,188 $ 2 $ (108) $ 692,082 Short-term investments: U.S. treasury securities $ 96,089 $ 10 $ (251) $ 95,848 U.S. government agency securities 339,957 6 (6,628) 333,335 Corporate debt securities 293,968 — (5,022) 288,946 Total short-term investments $ 730,014 $ 16 $ (11,901) $ 718,129 Total cash equivalents and short-term investments $ 1,422,202 $ 18 $ (12,009) $ 1,410,211
Schedule of Maturities	The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of October 31, 2022: Amortized Fair Value (in thousands) Due within one year $ 560,556 $ 555,971 Due between one to three years 193,782 183,874 Total $ 754,338 $ 739,845
Schedule of Unrealized Loss on Investments	Short-term investments that were in an unrealized loss position as of October 31, 2022, consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 149,458 $ (116) $ 9,898 $ (102) $ 159,356 $ (218) U.S. government agency securities 120,505 (1,966) 191,135 (6,459) 311,640 (8,425) Corporate debt securities 60,270 (2,518) 146,058 (3,337) 206,328 (5,855) Total $ 330,233 $ (4,600) $ 347,091 $ (9,898) $ 677,324 $ (14,498) Short-term investments that were in an unrealized loss position consisted of the following as of July 31, 2022, consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 80,833 $ (251) $ — $ — $ 80,833 $ (251) U.S. government agency securities 230,670 (5,150) 50,134 (1,478) 280,804 (6,628) Corporate debt securities 155,968 (3,947) 71,127 (1,075) 227,095 (5,022) Total $ 467,471 $ (9,348) $ 121,261 $ (2,553) $ 588,732 $ (11,901)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of October 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 157,756 $ 157,756 $ — $ — U.S. treasury securities 133,010 — 133,010 — U.S. government agency securities 336,444 — 336,444 — Corporate debt securities 225,567 — 225,567 — Total cash equivalents $ 852,777 $ 157,756 $ 695,021 $ — Short-term investments: U.S. treasury securities $ 174,364 $ — $ 174,364 $ — U.S. government agency securities 311,640 — 311,640 — Corporate debt securities 253,841 — 253,841 — Total short-term investments $ 739,845 $ — $ 739,845 $ — Total cash equivalents and short-term investments $ 1,592,622 $ 157,756 $ 1,434,866 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 574 $ — $ 574 $ — Foreign currency contract assets-noncurrent (2) $ 1,402 $ — $ 1,402 $ — Foreign currency contracts liabilities-current (3) $ 20,207 $ — $ 20,207 $ — Foreign currency contracts liabilities-noncurrent (4) $ 1,718 $ — $ 1,718 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 615 $ — $ 615 $ — Foreign currency contracts liabilities-current (3) $ 4,232 $ — $ 4,232 $ — (1) Reported as prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Reported as other noncurrent assets in the condensed consolidated balance sheets. (3) Reported as accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Reported as other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Reported as prepaid expenses and other current assets in the consolidated balance sheets. (2) Reported as other noncurrent assets in the consolidated balance sheets. (3) Reported as accrued expenses and other current liabilities in the consolidated balance sheets. (4) Reported as other noncurrent liabilities in the consolidated balance sheets.
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of October 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 157,756 $ 157,756 $ — $ — U.S. treasury securities 133,010 — 133,010 — U.S. government agency securities 336,444 — 336,444 — Corporate debt securities 225,567 — 225,567 — Total cash equivalents $ 852,777 $ 157,756 $ 695,021 $ — Short-term investments: U.S. treasury securities $ 174,364 $ — $ 174,364 $ — U.S. government agency securities 311,640 — 311,640 — Corporate debt securities 253,841 — 253,841 — Total short-term investments $ 739,845 $ — $ 739,845 $ — Total cash equivalents and short-term investments $ 1,592,622 $ 157,756 $ 1,434,866 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 574 $ — $ 574 $ — Foreign currency contract assets-noncurrent (2) $ 1,402 $ — $ 1,402 $ — Foreign currency contracts liabilities-current (3) $ 20,207 $ — $ 20,207 $ — Foreign currency contracts liabilities-noncurrent (4) $ 1,718 $ — $ 1,718 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 615 $ — $ 615 $ — Foreign currency contracts liabilities-current (3) $ 4,232 $ — $ 4,232 $ — (1) Reported as prepaid expenses and other current assets in the condensed consolidated balance sheets. (2) Reported as other noncurrent assets in the condensed consolidated balance sheets. (3) Reported as accrued expenses and other current liabilities in the condensed consolidated balance sheets. (4) Reported as other noncurrent liabilities in the condensed consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2022: Level I Level II Level III Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Cash equivalents: (in thousands) Money market funds $ 247,613 $ 247,613 $ — $ — U.S. treasury securities 202,708 — 202,708 — U.S. government agency securities 135,489 — 135,489 — Corporate debt securities 106,272 — 106,272 — Total $ 692,082 $ 247,613 $ 444,469 $ — Short-term investments: U.S. treasury securities $ 95,848 $ — $ 95,848 $ — U.S. government agency securities 333,335 — 333,335 — Corporate debt securities 288,946 — 288,946 — Total $ 718,129 $ — $ 718,129 $ — Total cash equivalents and short-term investments $ 1,410,211 $ 247,613 $ 1,162,598 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 178 $ — $ 178 $ — Foreign currency contract assets-noncurrent (2) $ 17 $ — $ 17 $ — Foreign currency contracts liabilities-current (3) $ 10,921 $ — $ 10,921 $ — Foreign currency contracts liabilities-noncurrent (4) $ 588 $ — $ 588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 452 $ — $ 452 $ — Foreign currency contracts liabilities-current (3) $ 3,427 $ — $ 3,427 $ — (1) Reported as prepaid expenses and other current assets in the consolidated balance sheets. (2) Reported as other noncurrent assets in the consolidated balance sheets. (3) Reported as accrued expenses and other current liabilities in the consolidated balance sheets. (4) Reported as other noncurrent liabilities in the consolidated balance sheets.

Property and Equipment and Pu_2

Property and Equipment and Purchased Intangible Assets (Tables)	3 Months Ended
	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: October 31, 2022 July 31, 2022 (in thousands) Hosting equipment $ 214,698 $ 191,037 Capitalized internal-use software 83,915 72,267 Computers and equipment 7,147 6,774 Purchased software 1,311 1,311 Furniture and fixtures 1,024 1,022 Leasehold improvements 7,339 7,339 Total property and equipment, gross 315,434 279,750 Less: Accumulated depreciation and amortization (132,009) (119,117) Total property and equipment, net $ 183,425 $ 160,633

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	3 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Intangible Assets	Acquired intangible assets subject to amortization consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount July 31, 2022 Additions October 31, 2022 July 31, 2022 Amortization Expense October 31, 2022 July 31, 2022 October 31, 2022 (in thousands) Developed technology $ 48,356 $ — $ 48,356 $ (18,972) $ (2,374) $ (21,346) $ 29,384 $ 27,010 Customer relationships 3,560 — 3,560 (1,125) (178) (1,303) 2,435 2,257 Total $ 51,916 $ — $ 51,916 $ (20,097) $ (2,552) $ (22,649) $ 31,819 $ 29,267
Schedule of Future Amortization Expense	Future amortization expense of acquired intangible assets consisted of the following: October 31, 2022 Year ending July 31, (in thousands) 2023 (remaining nine months) $ 7,369 2024 8,481 2025 7,778 2026 4,232 2027 1,407 Total $ 29,267

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Tables)	3 Months Ended
	Oct. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Cash Flow Hedges on our Consolidated Statement of Operations	The following table presents information about (gains) losses related to our cash flow hedges reclassified from AOCI into the condensed consolidated statement of operations for three months ended October 31, 2022 and 2021 : Three Months Ended October 31, 2022 2021 (in thousands) Classification: Cost of revenue $ 708 $ 5 Sales and marketing 3,297 380 Research and development 464 (27) General and administrative 244 (4) Total $ 4,713 $ 354

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	3 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Schedule of Convertible Senior Notes	The net carrying amount of the liability component of the Notes consisted of the following: October 31, July 31, 2022 2022 (in thousands) Principal amount $ 1,149,993 $ 1,149,995 Less: Unamortized debt discount (1) — 172,169 Unamortized debt issuance costs (1) 10,451 9,152 Net carrying amount $ 1,139,542 $ 968,674 (1) Effective August 1, 2022, we adopted ASU 2020-06. The adoption of this standard resulted in the elimination of the amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity will be classified to debt and amortized as interest expense. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended October 31, 2022 2021 (in thousands) Contractual interest expense $ 359 $ 359 Amortization of debt discount (1) — 12,796 Amortization of debt issuance costs (1) 972 680 Total $ 1,331 $ 13,835 (1) The decrease in total interest expense for the period ended October 31, 2022, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options	The activity of stock options consisted of the following for three months ended October 31, 2022: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2022 1,673 $ 11.81 2.5 $ 240,286 Exercised (109) 8.63 18,290 Canceled, forfeited or expired — — Balance as of October 31, 2022 1,564 $ 12.04 2.3 $ 222,120 Exercisable and expected to vest as of July 31, 2022 1,501 $ 10.78 2.4 $ 216,539 Exercisable and expected to vest as of October 31, 2022 1,441 $ 11.21 2.2 $ 205,855
Schedule of Restricted Stock Units and Performance Stock Awards Activity	The activity of restricted stock units ("RSUs") and performance stock awards ("PSAs") consisted of the following for three months ended October 31, 2022: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2022 7,388 $ 157.17 $ 1,145,526 Granted 1,637 174.79 Vested (1,019) 164.91 179,139 Canceled or forfeited (523) 167.95 Balance as of October 31, 2022 7,483 $ 159.22 $ 1,153,071
Schedule of Allocation of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following: Three Months Ended October 31, 2022 2021 (in thousands) Cost of revenue $ 8,432 $ 4,986 Sales and marketing 53,635 40,720 Research and development 24,531 27,259 General and administrative 18,575 16,938 Total $ 105,173 $ 89,903

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended 2022 2021 (in thousands) Net loss $ (68,162) $ (90,801) Weighted-average shares used in computing net loss per share, basic and diluted 143,476 139,296 Net loss per share, basic and diluted $ (0.48) $ (0.65)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table summarizes the potentially dilutive securities outstanding as of October 31, 2022 and 2021 that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: October 31, 2022 2021 (in thousands) Unvested RSUs and shares of common stock 6,870 7,085 Stock options 1,564 2,206 Unvested PSAs (1) 755 676 Share purchase rights under the ESPP 812 697 Notes 7,626 7,626 Total 17,627 18,290 (1)

Business and Summary of Signi_3

Business and Summary of Significant Accounting Policies (Details) shares in Thousands, $ in Thousands	Aug. 01, 2022 USD ($) shares	Oct. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Jul. 31, 2021 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total carrying value		$ 1,149,993	$ 1,149,995
Cumulative effect adjustment		431,275	573,300	$ 530,199	$ 528,895
Number of shares if notes converted (in shares) | shares	7,630
Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment		1,425,156	1,590,885	1,225,224	1,131,006
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment		$ (956,201)	(991,878)	$ (692,401)	$ (601,600)
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total carrying value	$ 169,900
Cumulative effect adjustment			(169,899)
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	(273,700)		(273,738)
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	$ 103,800		$ 103,839

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Concentration Risk [Line Items]
Deferred revenue	$ 1,005.7		$ 1,021.1
Contract with customer, liability, revenue recognized	329.3	$ 206.4
Revenue, remaining performance obligation	2,682
Accrued sales commissions	$ 21		$ 47.2
Minimum
Concentration Risk [Line Items]
Contract with customer, term of contract	1 year
Maximum
Concentration Risk [Line Items]
Contract with customer, term of contract	3 years
Transferred over Time | Product Concentration Risk | Subscription and Support | Revenue Benchmark
Concentration Risk [Line Items]
Concentration risk percentage	97%	97%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 355,548	$ 230,517
Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 355,548	$ 230,517
Revenue percentage	100%	100%
Revenue Benchmark | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 355,548	$ 230,517
Revenue percentage	100%	100%
Revenue Benchmark | Customer Concentration Risk | Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 329,357	$ 215,073
Revenue percentage	93%	93%
Revenue Benchmark | Customer Concentration Risk | Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 26,191	$ 15,444
Revenue percentage	7%	7%
United States | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 175,515	$ 113,413
Revenue percentage	49%	49%
Europe, Middle East and Africa | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 116,993	$ 80,549
Revenue percentage	33%	35%
Asia Pacific | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 52,270	$ 31,052
Revenue percentage	15%	14%
Other | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 10,770	$ 5,503
Revenue percentage	3%	2%

Revenue Recognition - Performan

Revenue Recognition - Performance Obligation (Details)	Oct. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	50%
Recognized transaction price period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	96%
Recognized transaction price period	3 years

Revenue Recognition - Capitaliz

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Changes in Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 297,002	$ 207,030
Capitalization of contract acquisition costs	26,795	23,985
Amortization of deferred contract acquisition costs	(22,325)	(14,912)
Ending balance	301,472	216,103
Deferred contract acquisition costs, current	90,004		$ 86,210
Deferred contract acquisition costs, noncurrent	211,468		210,792
Total deferred contract acquisition costs	$ 301,472	$ 216,103	$ 297,002

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Cash equivalents:
Amortized Cost	$ 852,923	$ 692,188
Unrealized Gains	0	2
Unrealized Losses	(146)	(108)
Fair Value	852,777	692,082
Short-term investments:
Amortized Cost	754,338	730,014
Unrealized Gains	5	16
Unrealized Losses	(14,498)	(11,901)
Fair Value	739,845	718,129
Total cash equivalents and short-term investments, amortized cost	1,607,261	1,422,202
Total cash equivalents and short-term investments, unrealized gains	5	18
Total cash equivalents and short-term investments, unrealized losses	(14,644)	(12,009)
Total cash equivalents and short-term investments	1,592,622	1,410,211
U.S. treasury securities
Short-term investments:
Amortized Cost	174,577	96,089
Unrealized Gains	5	10
Unrealized Losses	(218)	(251)
Fair Value	174,364	95,848
U.S. government agency securities
Short-term investments:
Amortized Cost	320,065	339,957
Unrealized Gains	0	6
Unrealized Losses	(8,425)	(6,628)
Fair Value	311,640	333,335
Corporate debt securities
Short-term investments:
Amortized Cost	259,696	293,968
Unrealized Gains	0	0
Unrealized Losses	(5,855)	(5,022)
Fair Value	253,841	288,946
Money market funds
Cash equivalents:
Amortized Cost	157,756	247,613
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	157,756	247,613
U.S. treasury securities
Cash equivalents:
Amortized Cost	133,029	202,778
Unrealized Gains	0	0
Unrealized Losses	(19)	(70)
Fair Value	133,010	202,708
U.S. government agency securities
Cash equivalents:
Amortized Cost	336,570	135,525
Unrealized Gains	0	2
Unrealized Losses	(126)	(38)
Fair Value	336,444	135,489
Corporate debt securities
Cash equivalents:
Amortized Cost	225,568	106,272
Unrealized Gains	0	0
Unrealized Losses	(1)	0
Fair Value	$ 225,567	$ 106,272

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Schedule of Maturities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Amortized Cost
Due within one year	$ 560,556
Due between one to three years	193,782
Amortized Cost	754,338	$ 730,014
Fair Value
Due within one year	555,971
Due between one to three years	183,874
Fair Value	$ 739,845	$ 718,129

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Position (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	$ 330,233	$ 467,471
Less than 12 months, unrealized losses	(4,600)	(9,348)
Greater than 12 months, fair value	347,091	121,261
Greater than 12 months, unrealized losses	(9,898)	(2,553)
Total fair value	677,324	588,732
Total unrealized losses	(14,498)	(11,901)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	149,458	80,833
Less than 12 months, unrealized losses	(116)	(251)
Greater than 12 months, fair value	9,898	0
Greater than 12 months, unrealized losses	(102)	0
Total fair value	159,356	80,833
Total unrealized losses	(218)	(251)
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	120,505	230,670
Less than 12 months, unrealized losses	(1,966)	(5,150)
Greater than 12 months, fair value	191,135	50,134
Greater than 12 months, unrealized losses	(6,459)	(1,478)
Total fair value	311,640	280,804
Total unrealized losses	(8,425)	(6,628)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	60,270	155,968
Less than 12 months, unrealized losses	(2,518)	(3,947)
Greater than 12 months, fair value	146,058	71,127
Greater than 12 months, unrealized losses	(3,337)	(1,075)
Total fair value	206,328	227,095
Total unrealized losses	$ (5,855)	$ (5,022)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Cash and Cash Equivalents [Abstract]
Accrued interest receivable	$ 1.5	$ 1.3
Investment carrying value	$ 5.8	$ 5.1

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Cash equivalents:
Fair Value	$ 852,777	$ 692,082
Short-term investments:
Short-term investments	739,845	718,129
Total cash equivalents and short-term investments	1,592,622	1,410,211
Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	852,777	692,082
Short-term investments:
Short-term investments	739,845	718,129
Total cash equivalents and short-term investments	1,592,622	1,410,211
Fair Value, Measurements, Recurring | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	574	178
Foreign currency contract assets-noncurrent	1,402	17
Foreign currency contracts liabilities-current	20,207	10,921
Foreign currency contracts liabilities-noncurrent	1,718	588
Non-designated derivative instruments:
Foreign currency contract assets-current	574	178
Foreign currency contracts liabilities-current	20,207	10,921
Fair Value, Measurements, Recurring | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	615	452
Foreign currency contracts liabilities-current	4,232	3,427
Non-designated derivative instruments:
Foreign currency contract assets-current	615	452
Foreign currency contracts liabilities-current	4,232	3,427
Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	157,756	247,613
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	157,756	247,613
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	695,021	444,469
Short-term investments:
Short-term investments	739,845	718,129
Total cash equivalents and short-term investments	1,434,866	1,162,598
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	574	178
Foreign currency contract assets-noncurrent	1,402	17
Foreign currency contracts liabilities-current	20,207	10,921
Foreign currency contracts liabilities-noncurrent	1,718	588
Non-designated derivative instruments:
Foreign currency contract assets-current	574	178
Foreign currency contracts liabilities-current	20,207	10,921
Fair Value, Measurements, Recurring | Level II | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	615	452
Foreign currency contracts liabilities-current	4,232	3,427
Non-designated derivative instruments:
Foreign currency contract assets-current	615	452
Foreign currency contracts liabilities-current	4,232	3,427
Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contract assets-noncurrent	0	0
Foreign currency contracts liabilities-current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Foreign currency contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Non-designated derivative instruments:
Foreign currency contract assets-current	0	0
Foreign currency contracts liabilities-current	0	0
U.S. treasury securities
Short-term investments:
Short-term investments	174,364	95,848
U.S. treasury securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	174,364	95,848
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	174,364	95,848
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
U.S. government agency securities
Short-term investments:
Short-term investments	311,640	333,335
U.S. government agency securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	311,640	333,335
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	311,640	333,335
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Corporate debt securities
Short-term investments:
Short-term investments	253,841	288,946
Corporate debt securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	253,841	288,946
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	253,841	288,946
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Fair Value	157,756	247,613
Money market funds | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	157,756	247,613
Money market funds | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	157,756	247,613
Money market funds | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	0	0
Money market funds | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. treasury securities
Cash equivalents:
Fair Value	133,010	202,708
U.S. treasury securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	133,010	202,708
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	133,010	202,708
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. government agency securities
Cash equivalents:
Fair Value	336,444	135,489
U.S. government agency securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	336,444	135,489
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	336,444	135,489
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Corporate debt securities
Cash equivalents:
Fair Value	225,567	106,272
Corporate debt securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	225,567	106,272
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	225,567	106,272
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	$ 0	$ 0

Property and Equipment and Pu_3

Property and Equipment and Purchased Intangible Assets - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 315,434	$ 279,750
Less: Accumulated depreciation and amortization	(132,009)	(119,117)
Total property and equipment, net	183,425	160,633
Hosting equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	214,698	191,037
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	83,915	72,267
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	7,147	6,774
Purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,311	1,311
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	1,024	1,022
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 7,339	$ 7,339

Property and Equipment and Pu_4

Property and Equipment and Purchased Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	$ 51,916		$ 51,916
Accumulated amortization	22,649		20,097
Depreciation and amortization expense	11,876	$ 9,017
Capitalized software, amortization expense	$ 1,700	$ 800
IP Addresses
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	10 years
Historical cost	$ 8,600		6,400
Accumulated amortization	$ 1,000		$ 800

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 78,547		$ 78,547
Amortization expense of acquired intangible assets	$ 2,552	$ 2,226

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance	$ 51,916
Additions	0
Intangible Assets, Gross, ending balance	51,916
Accumulated Amortization, beginning balance	(20,097)
Amortization Expense	(2,552)	$ (2,226)
Accumulated Amortization, ending balance	(22,649)
Total	29,267		$ 31,819
Developed technology
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance	48,356
Additions	0
Intangible Assets, Gross, ending balance	48,356
Accumulated Amortization, beginning balance	(18,972)
Amortization Expense	(2,374)
Accumulated Amortization, ending balance	(21,346)
Total	27,010		29,384
Customer relationships
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance	3,560
Additions	0
Intangible Assets, Gross, ending balance	3,560
Accumulated Amortization, beginning balance	(1,125)
Amortization Expense	(178)
Accumulated Amortization, ending balance	(1,303)
Total	$ 2,257		$ 2,435

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remaining nine months)	$ 7,369
2024	8,481
2025	7,778
2026	4,232
2027	1,407
Total	$ 29,267	$ 31,819

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Derivative [Line Items]
Loss recognized on cash flow hedges	$ 14,039	$ 1,304
Maximum
Derivative [Line Items]
Term of derivative	24 months
Not Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	$ 162,400		$ 126,400
Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	$ 446,100		$ 293,400
Foreign currency contracts | Not Designated as Hedging Instrument | Minimum
Derivative [Line Items]
Term of derivative	1 month
Foreign currency contracts | Not Designated as Hedging Instrument | Maximum
Derivative [Line Items]
Term of derivative	4 months

Derivative Instruments - Cash F

Derivative Instruments - Cash Flow Hedges on our Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 4,713	$ 354
Cost of revenue
Derivative Instruments, Gain (Loss) [Line Items]
Total	708	5
Sales and marketing
Derivative Instruments, Gain (Loss) [Line Items]
Total	3,297	380
Research and development
Derivative Instruments, Gain (Loss) [Line Items]
Total	464	(27)
General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 244	$ (4)

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details) - USD ($)	Jun. 25, 2020	Oct. 31, 2022	Jul. 31, 2022
Debt Instrument [Line Items]
Proceeds from debt issuance	$ 1,130,500,000
Fair value of notes		$ 1,416,700,000	$ 1,418,500,000
Initial strike price (in dollars per share)	$ 150.80
Initial cap price (in dollars per shares)	$ 246.76
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal amount	$ 1,150,000,000
Interest rate	0.125%
Convertible Senior Notes, $150 million
Debt Instrument [Line Items]
Principal amount	$ 150,000,000

Convertible Senior Notes - Carr

Convertible Senior Notes - Carrying Amounts (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jul. 31, 2022
Convertible Debt [Abstract]
Principal amount	$ 1,149,993	$ 1,149,995
Unamortized debt discount	0	172,169
Unamortized debt issuance costs	10,451	9,152
Net carrying amount	$ 1,139,542	$ 968,674

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Debt Disclosure [Abstract]
Contractual interest expense	$ 359	$ 359
Amortization of debt discount	0	12,796
Amortization of debt issuance costs	972	680
Total	$ 1,331	$ 13,835

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2022	Jul. 31, 2022
Letter of Credit
Loss Contingencies [Line Items]
Aggregate value of unsecured letters of credits	$ 2.1	$ 2.1

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Outstanding Stock Options
Beginning balance (in shares)	1,673
Exercised (in shares)	(109)
Canceled, forfeited or expired (in shares)	0
Ending balance (in shares)	1,564		1,673
Exercisable and expected to vest (in shares)	1,441		1,501
Weighted-Average Exercise Price
Beginning balance (in dollars per share)	$ 11.81
Exercised (in dollars per share)	8.63
Canceled, forfeited or expired (in dollars per share)	0
Ending balance (in dollars per share)	12.04		$ 11.81
Exercisable and expected to vest (in dollars per share)	$ 11.21		$ 10.78
Additional Disclosures
Options outstanding, weighted average remaining contractual term	2 years 3 months 18 days		2 years 6 months
Exercisable and expected to vest, weighted average remaining contractual term	2 years 2 months 12 days		2 years 4 months 24 days
Options outstanding, aggregate intrinsic value	$ 222,120		$ 240,286
Exercised, aggregate intrinsic value	18,290	$ 100,700
Exercisable and expected to vest, aggregate intrinsic value	$ 205,855		$ 216,539

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercised, aggregate intrinsic value		$ 18,290	$ 100,700
Granted (in shares)		0
Reversal of stock-based compensation		$ 105,173	89,903
Incremental compensation cost		5,600
Capitalized stock-based compensation		$ 4,000	$ 2,500
President
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of stock-based compensation	$ (9,900)
Performance stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares outstanding (in shares)	100,000	100,000
Employee Stock | 2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accrued compensation	$ 12,600	$ 12,600		$ 4,700
Issuance of unvested shares (in shares)		0

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of RSU and PSA Activity (Details) - Restricted Stock Units and Performance Stock Awards - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2022	Jul. 31, 2022
Underlying Shares
Beginning balance (in shares)	7,388
Granted (in shares)	1,637
Vested (in shares)	(1,019)
Canceled or forfeited (in shares)	(523)
Ending balance (in shares)	7,483
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 157.17
Granted (in dollars per share)	174.79
Vested (in dollars per share)	164.91
Canceled or forfeited (in shares)	167.95
Ending balance (in dollars per share)	$ 159.22
Aggregate Intrinsic Value
Balance	$ 1,153,071	$ 1,145,526
Vested	$ 179,139

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	$ 105,173	$ 89,903
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	8,432	4,986
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	53,635	40,720
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	24,531	27,259
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total	$ 18,575	$ 16,938

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Provision (benefit) for income taxes	$ 4,746	$ 2,479

Net Loss Per Share - Net Loss P

Net Loss Per Share - Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Earnings Per Share [Abstract]
Net loss, basic	$ (68,162)	$ (90,801)
Net loss, diluted	$ (68,162)	$ (90,801)
Weighted-average shares used in computing net loss per share, basic (in shares)	143,476	139,296
Weighted-average shares used in computing net loss per share, diluted (in shares)	143,476	139,296
Net loss per share, basic (in dollars per share)	$ (0.48)	$ (0.65)
Net loss per share, diluted (in dollars per share)	$ (0.48)	$ (0.65)

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	Oct. 31, 2022 $ / shares
Earnings Per Share [Abstract]
Conversion price (in dollars per share)	$ 150.80

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation (Details) - shares shares in Thousands	3 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	17,627	18,290
Unvested RSUs and shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	6,870	7,085
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,564	2,206
Unvested PSAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	755	676
Number of unvested PSAs as a percentage of target	100%	100%
Share purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	812	697
Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	7,626	7,626